MetLife Investment Management LLC increased its position in Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) by 4.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 310,093 shares of the company's stock after buying an additional 12,201 shares during the period. MetLife Investment Management LLC's holdings in Keurig Dr Pepper were worth $10,611,000 at the end of the most recent reporting period.
A number of other hedge funds have also added to or reduced their stakes in KDP. China Universal Asset Management Co. Ltd. boosted its stake in shares of Keurig Dr Pepper by 51.8% in the 1st quarter. China Universal Asset Management Co. Ltd. now owns 33,510 shares of the company's stock worth $1,154,000 after buying an additional 11,435 shares during the last quarter. Praxis Investment Management Inc. boosted its stake in shares of Keurig Dr Pepper by 112.2% in the 1st quarter. Praxis Investment Management Inc. now owns 19,630 shares of the company's stock worth $672,000 after buying an additional 10,380 shares during the last quarter. Aspire Private Capital LLC purchased a new position in shares of Keurig Dr Pepper in the 1st quarter worth approximately $1,177,000. Envestnet Asset Management Inc. boosted its stake in shares of Keurig Dr Pepper by 13.7% in the 1st quarter. Envestnet Asset Management Inc. now owns 2,823,185 shares of the company's stock worth $96,609,000 after buying an additional 339,530 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. boosted its stake in shares of Keurig Dr Pepper by 656.1% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 205,556 shares of the company's stock worth $7,034,000 after buying an additional 178,368 shares during the last quarter. Institutional investors and hedge funds own 93.99% of the company's stock.
Analysts Set New Price Targets
A number of equities analysts have recently weighed in on KDP shares. Deutsche Bank Aktiengesellschaft cut their target price on Keurig Dr Pepper from $40.00 to $38.00 and set a "buy" rating on the stock in a research note on Tuesday. JPMorgan Chase & Co. cut their target price on Keurig Dr Pepper from $39.00 to $38.00 and set an "overweight" rating on the stock in a research note on Thursday, July 17th. Hsbc Global Res downgraded Keurig Dr Pepper from a "strong-buy" rating to a "hold" rating in a research note on Tuesday. HSBC reiterated a "hold" rating and issued a $30.00 price objective (down previously from $42.00) on shares of Keurig Dr Pepper in a research note on Tuesday. Finally, Jefferies Financial Group set a $41.00 price objective on Keurig Dr Pepper in a research note on Monday. Eleven research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $38.38.
View Our Latest Research Report on Keurig Dr Pepper
Insider Buying and Selling at Keurig Dr Pepper
In other news, Director De Ven Michael G. Van purchased 15,000 shares of the firm's stock in a transaction dated Wednesday, June 4th. The shares were purchased at an average price of $33.20 per share, with a total value of $498,000.00. Following the completion of the acquisition, the director owned 15,000 shares in the company, valued at $498,000. This trade represents a ∞ increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Mary Beth Denooyer sold 12,000 shares of the company's stock in a transaction on Thursday, July 17th. The stock was sold at an average price of $33.66, for a total transaction of $403,920.00. Following the completion of the transaction, the insider directly owned 82,511 shares in the company, valued at approximately $2,777,320.26. The trade was a 12.70% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 679,601 shares of company stock valued at $22,508,712 in the last 90 days. 0.40% of the stock is currently owned by company insiders.
Keurig Dr Pepper Stock Performance
KDP stock traded down $0.20 during midday trading on Friday, reaching $29.09. 22,200,454 shares of the company's stock traded hands, compared to its average volume of 14,551,858. The company has a 50-day moving average price of $33.36 and a two-hundred day moving average price of $33.58. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.40 and a current ratio of 0.64. Keurig Dr Pepper, Inc has a 52 week low of $28.70 and a 52 week high of $38.28. The firm has a market capitalization of $39.52 billion, a PE ratio of 25.97, a price-to-earnings-growth ratio of 1.60 and a beta of 0.45.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last issued its earnings results on Thursday, July 24th. The company reported $0.49 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.49. Keurig Dr Pepper had a net margin of 9.75% and a return on equity of 11.05%. The business had revenue of $4.16 billion for the quarter, compared to analysts' expectations of $4.14 billion. During the same quarter in the previous year, the firm posted $0.45 EPS. The business's revenue for the quarter was up 6.1% compared to the same quarter last year. As a group, equities analysts anticipate that Keurig Dr Pepper, Inc will post 1.92 EPS for the current year.
Keurig Dr Pepper Profile
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Featured Stories

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.